Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02476955
Title Open-label Phase 1b Study of ARQ 092 in Combination With Carboplatin Plus Paclitaxel
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors ArQule
Indications

Advanced Solid Tumor

Therapies

Miransertib

Carboplatin + Paclitaxel

Age Groups: adult
Covered Countries USA


No variant requirements are available.